NIAID Releases H5N1 Influenza Research Agenda
June 5, 2024
NIAID has issued its plan for advancing H5N1 influenza basic research and translating those findings into strategies and interventions that can benefit people. The research agenda focuses on four key objectives: increasing understanding of the biology of H5N1 viruses and the factors that influence their ability to transmit and cause disease; developing and evaluating prevention strategies, such as vaccines; advancing existing and novel treatments, including antivirals and monoclonal antibodies; and supporting strategies for detecting H5N1 virus. The new research agenda, which builds on the Institute's longstanding influenza research efforts, aligns with NIAID's role in the federal public health response to the U.S. outbreak of H5N1 influenza in people, dairy cows and other animals.